JETEMA
Kaimax
Brand
JETEMA
Category
Botulinum Toxin
Origin
Korea
Options
100 unit · 200 unit
Available options
Interested in ordering Kaimax? Send an enquiry and our team will follow up with availability and pricing.
Overview
Kaimax is a Korean botulinum toxin type A injectable listed by distributors as a product of JETEMA Co., Ltd., a South Korean aesthetics manufacturer. It is a high-purity type A toxin supplied primarily in 100 unit vials (a 200 unit presentation is also referenced) and is marketed as KFDA-approved for professional aesthetic use.
How it works
Botulinum toxin type A binds to presynaptic cholinergic nerve terminals and cleaves the SNAP-25 protein, blocking acetylcholine release at the neuromuscular junction. This temporarily relaxes the target muscle, reducing dynamic wrinkling. The effect is reversible, generally lasting around 3-4 months before muscle activity returns.
Indications
- Glabellar (frown) lines
- Forehead lines
- Crow's feet
- Masseter reduction / facial contouring
Key features
- Type A toxin attributed to JETEMA Co., Ltd.
- Vacuum-dried preparation
- High purity, low immunogenicity positioning
- 100U (and 200U) vial formats
- KFDA-approved per distributor listings
Benefits
- Reliable, standardised unit potency
- Cost-efficient option among Korean toxins
- Purity profile intended to limit antibody formation
- Suitable across common aesthetic indications
Composition
Botulinum toxin type A complex, supplied in 100 unit vials (200 unit also referenced), with human serum albumin and sodium chloride as standard excipients for the class. Described by distributors as a highly purified, vacuum-dried preparation.
Usage & handling
Reconstitute the dried powder with preservative-free 0.9% sterile saline before injection. Because it is vacuum-dried, the vial may appear nearly empty or show only a thin film, which is expected. Store refrigerated at 2-8C; for use by trained injectors.
For medical professionals. Product information is for reference and does not replace the manufacturer's instructions for use. Availability and regulatory status vary by region.